During the past decade, Memorial Sloan-Kettering Cancer Center SC conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Memorial Sloan-Kettering Cancer Center SC" are "Acromegaly" (1 trials), "Advanced Solid Tumors" (1 trials), "Cushing's Disease" (1 trials), "Dumping Syndrome" (1 trials) and "Ectopic ACTH Secreting (EAS) Tumors" (1 trials). Many other conditions were trialed in "Memorial Sloan-Kettering Cancer Center SC" in a lesser frequency.

Most popular intervention types in "Memorial Sloan-Kettering Cancer Center SC" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cabergoline" (1 trials), "LAG525" (1 trials), "PDR001" (1 trials) and "Pasireotide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Sloan-Kettering Cancer Center SC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Memorial Sloan-Kettering Cancer Center SC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Memorial Sloan-Kettering Cancer Center SC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Sloan-Kettering Cancer Center SC, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".